Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus …

B Heidecker, N Dagan, R Balicer… - European journal of …, 2022 - Wiley Online Library
Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors,
recombinant protein, and inactivated virus have been administered worldwide. Although …

Impact of COVID-19 on cardiovascular disease

I Vosko, A Zirlik, H Bugger - Viruses, 2023 - mdpi.com
Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

[HTML][HTML] Intramyocardial inflammation after COVID-19 vaccination: an endomyocardial biopsy-proven case series

C Baumeier, G Aleshcheva, D Harms, U Gross… - International Journal of …, 2022 - mdpi.com
Myocarditis in response to COVID-19 vaccination has been reported since early 2021. In
particular, young male individuals have been identified to exhibit an increased risk of …

Long-term prognosis of patients with myocarditis attributed to COVID-19 mRNA vaccination, SARS-CoV-2 infection, or conventional etiologies

L Semenzato, S Le Vu, J Botton, M Bertrand, MJ Jabagi… - JAMA, 2024 - jamanetwork.com
Importance Although patients with myocarditis after COVID-19 mRNA vaccination appear to
have a good prognosis near hospital discharge, their longer-term prognosis and …

Myopericarditis after COVID-19 mRNA vaccination among adolescents and young adults: a systematic review and meta-analysis

J Yasuhara, K Masuda, T Aikawa, T Shirasu… - JAMA …, 2023 - jamanetwork.com
Importance Published data on COVID-19 mRNA vaccine–associated myopericarditis in
adolescents and young adults have been derived from small case series, national …

[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

Role of endomyocardial biopsy in diagnostics of myocarditis

L Vidusa, O Kalejs, A Maca-Kaleja, I Strumfa - Diagnostics, 2022 - mdpi.com
Endomyocardial biopsy as the cornerstone of diagnostics has been re-evaluated throughout
the years, leaving unanswered questions on the precedence of it. The reported incidence of …

Overview of SARS-CoV-2 infection and vaccine associated myocarditis compared to non-COVID-19-associated myocarditis: A systematic review and meta-analysis

Y Ishisaka, A Watanabe, T Aikawa, K Kanaoka… - International Journal of …, 2024 - Elsevier
Background Previous literature suggests that both SARS-CoV-2 infection and COVID-19
mRNA vaccine are associated with myocarditis, in which the incidence is higher in the …

[HTML][HTML] Do COVID-19 viral infection and its mRNA vaccine carry an equivalent risk of myocarditis? Review of the current evidence, insights, and future directions

AS Ulucay, G Singh, SH Kanuri - Indian Heart Journal, 2023 - Elsevier
According to recent epidemiological analysis, the percentage of world population infected
with COVID-19 by end of December 2020 is approximately 12.56% 1. COVID induced acute …

Serious harms of the COVID-19 vaccines: a systematic review

PC Gøtzsche, M Demasi - MedRxiv, 2022 - medrxiv.org
Introduction Serious harms of the COVID-19 vaccines have been underreported in
published trial reports. Methods Systematic review of papers with data on serious adverse …